Search

everythinglearnresearchcommunity

for

Search:↓

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Testosterone's effects on COVID-19 are unclear and need more research.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Boosting HGF signaling could improve the creation of hair follicles in lab-made skin.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

The skin and thymus develop similarly to protect and support immunity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.